JILIN JIAN YISHENG PHARMACEUTICAL CO.,LTD. is principally engaged in the research, development, production and distribution of Chinese patent drugs. The Company mainly provides Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The Company's products are primarily applied in the treatment for heart cerebrovascular diseases, respiratory system diseases, alimentary system diseases, endocrine system diseases, urinary system diseases, tumors and paediatric diseases, among others. During the year ended December 31, 2010, the Company obtained approximately 35%, 30% and 22% of its total revenue from the sale of Shengmai injections, Zhenyuan capsules and Qingkailing injections.